Получение и свойства гидрогелевых наночастиц пектината кальция с транс-коричной кислотой

Hydrogel negatively charged (–13.5 ± 5.0 mV) calcium pectinate nano- and submicroparticles (50–150 nm) were obtained. A technique for entrapment of a plant growth regulator (trans-cinnamic acid) in the particles up to 40 wt. % has been developed. It has been established that the complete release of trans-cinnamic acid in the Murashige–Skoog medium takes 2.5 hours. The obtained particles of calcium pectinate do not affect the growth processes of cells in suspension culture and can be used as neutral carriers for growth regulators.Получены отрицательно заряженные (–13,5 ± 5,0 мВ) гидрогелевые нано- и субмикрочастицы (50–150 нм) пектината кальция. Разработана методика, позволяющая включать в них до 40 мас. % регулятора роста растений – транс-коричную кислоту (ТКК). Установлено, что полное высвобождение ТКК в среде культивирования клеток (Мурасиге–Скуга) протекает за 2,5 ч. Полученные частицы пектината кальция не влияют на ростовые процессы клеток суспензионной культуры и могут быть использованы в качестве нейтральных носителей регуляторов роста

SELECTION OF AN ANTIRETROVIRAL REGIMEN BASED ON THE RESISTANCE DATA

As part of the global strategy against HIV, UNAIDS formulated the 90-90--90 targets. The targets mean that 90% of people living with HIV and receiving treatment should have achieved viral suppression. One of the main obstacles to achieving the goal is HIV resistance to antiretroviral therapy. It occurs when the virus mutates and affinity of active ingredients of drugs for the corresponding viral proteins is reduced. Drugs differ by the genetic barrier. Non-nucleoside reverse-transcriptase inhibitors lose their ability to inhibit the replication after a single mutation, and ritonavir- boosted protease inhibitors - after 5--8th mutation. The key factor for adequate viral suppression and reduction of risks is good adherence to treatment. Medication non-adherence creates a favorable environment in the body for the evolution of the virus. In the Russian Federation, the prevalence of primary resistance reaches 6.02%, and poor adherence equals 26%. The data and the results of examinations for mutations should be considered when selecting an antiretroviral regimen and approach to patient to improve adherence

SUBACUTE MYOCARDITIS: MYTHS AND REALITY

Clinical case of subacute myocarditis is presented, complexity of its diagnosis and management are considered

HIV care in times of the COVID-19 crisis — Where are we now in Central and Eastern Europe?

Introduction The SARS-CoV-2 pandemic has hit the European region disproportionately. Many HIV clinics share staff and logistics with infectious disease facilities, which are now on the frontline in tackling COVID-19. Therefore, this study investigated the impact of the current pandemic situation on HIV care and continuity of antiretroviral treatment (ART) supplies in CEE countries. Methods The Euroguidelines in Central and Eastern Europe (ECEE) Network Group was established in February 2016 to review standards of care for HIV in the region. The group consists of professionals actively involved in HIV care. On March 19, 2020 we decided to review the status of HIV care sustainability in the face of the emerging SARS-CoV-2 pandemic in Europe. For this purpose, we constructed an online survey consisting of 23 questions. Respondents were recruited from ECEE members in 22 countries, based on their involvement in HIV care, and contacted via email. Results In total, 19 countries responded: Albania, Armenia, Belarus, Bosnia and Herzegovina, Bulgaria, Croatia, Czech Republic, Estonia, Georgia, Greece, Hungary, Lithuania, Macedonia, Poland, Republic of Moldova, Russia, Serbia, Turkey, and Ukraine. Most of the respondents were infectious disease physicians directly involved in HIV care (17/19). No country reported HIV clinic closures. HIV clinics were operating normally in only six countries (31.6%). In 11 countries (57.9%) physicians were sharing HIV and COVID-19 care duties. None of the countries expected shortage of ART in the following 2 weeks; however, five physicians expressed uncertainty about the following 2 months. At the time of providing responses, ten countries (52.6%) had HIV-positive persons under quarantine. Conclusions A shortage of resources is evident, with an impact on HIV care inevitable. We need to prepare to operate with minimal medical resources, with the aim of securing constant supplies of ART. Non-governmental organizations should re-evaluate their earlier objectives and support efforts to ensure continuity of ART delivery